<!DOCTYPE html>
<html>

<head>
  <title>Inflammation and Repair</title>
  <link rel="stylesheet" type="text/css" href="/style/bookstyle.css">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script src="/script/otherSources.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5.15.3/css/all.min.css">

</head>

<body>

  <div class="left-box-container">
    <div class="unit-left-lesson">
        <div class="unit-left"></div>
        <div class="lesson-no-box" id="lesson-no-id"></div>
    </div>
    <div class="unit-name-box" id="unit-name-id"></div>
</div>

<div class="header-center">
    <div class="lesson-name" id="lesson-name-id"></div>
    <div class="tab-bar">
        <div class="tab active-tab" onclick="openContainer(event, 'home')">Home</div>
        <div class="tab" onclick="openContainer(event, 'questions')">Questions</div>
        <div class="tab" onclick="openContainer(event, 'videos')">Videos</div>
        <div class="tab" onclick="openContainer(event, 'remnant')">Remnant memory</div>
    </div>
</div>

<script>
    var contentPageLocation = "../contentRobbins.html";
</script>


  <div class="menu-toggle-btn" id="menu-toggle-btn-id">
    <i class="fas fa-bars"></i>
  </div>

  <main>
  <div class="sidebar tab " id="sidebar-id">

  </div>











  <div id="home-container" class="container">


    <h1>Overview of Inflammation: Definitions and General Features</h1>
    <h2>Definitions</h2>
    <p>Inflammation is a complex biological response of the body to harmful stimuli, such as pathogens, tissue injury,
      or irritants. It is a protective mechanism aimed at removing the injurious agent, initiating tissue repair, and
      restoring homeostasis.</p>
    <p>Acute inflammation refers to a rapid and short-term response characterized by the classic signs of inflammation:
      redness (rubor), heat (calor), swelling (tumor), pain (dolor), and loss of function (functio laesa).</p>
    <p>Chronic inflammation, on the other hand, is a prolonged inflammatory response that can persist for weeks, months,
      or even years. It involves the infiltration of immune cells, tissue destruction, and attempts at tissue repair.
      Chronic inflammation is associated with various diseases, including autoimmune disorders, persistent infections,
      and some types of cancer.</p>
    <table>
      <caption>Differences between Acute and Chronic Inflammation</caption>
      <thead>
        <tr>
          <th>Property</th>
          <th>Acute Inflammation</th>
          <th>Chronic Inflammation</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Duration</td>
          <td>Short duration, usually lasting hours to a few days</td>
          <td>Prolonged duration, lasting weeks, months, or even years</td>
        </tr>
        <tr>
          <td>Characteristics</td>
          <td>Exudation of fluid and plasma proteins</td>
          <td>Tissue destruction and repair</td>
        </tr>
        <tr>
          <td>Infiltrating Cells</td>
          <td>Neutrophils</td>
          <td>Lymphocytes and macrophages</td>
        </tr>
        <tr>
          <td>Pathological Features</td>
          <td>Fibrin exudates and neutrophilic infiltrates</td>
          <td>Granulomas, fibrosis, and tissue scarring</td>
        </tr>
        <tr>
          <td>Tissue Damage</td>
          <td>Limited tissue damage</td>
          <td>Progressive tissue damage</td>
        </tr>
        <tr>
          <td>Outcome</td>
          <td>Resolution is the usual outcome</td>
          <td>Healing occurs with tissue remodeling and scarring</td>
        </tr>
        <tr>
          <td>Associated Conditions</td>
          <td>Acute infections, tissue injury, and immune responses</td>
          <td>Persistent infections, autoimmune diseases, and prolonged exposure to injurious agents</td>
        </tr>
      </tbody>
    </table>
    <h2>General Features</h2>
    <p>Inflammation involves a series of coordinated events, including vascular changes, recruitment of immune cells,
      and the release of inflammatory mediators. Some of the general features of inflammation include:</p>
    <ul>
      <li><strong>Vasodilation:</strong> Blood vessels near the site of inflammation dilate, leading to increased blood
        flow, which causes redness and heat.</li>
      <li><strong>Increase in vascular permeability:</strong> Blood vessels become leaky, allowing fluid, proteins, and
        immune cells to migrate from the bloodstream into the affected tissues, resulting in swelling.</li>
      <li><strong>Recruitment of immune cells:</strong> Various immune cells, including neutrophils, monocytes, and
        lymphocytes, are attracted to the site of inflammation to combat the injurious agent.</li>
      <li><strong>Release of inflammatory mediators:</strong> Immune cells and other cells at the site of inflammation
        release various molecules, such as cytokines, chemokines, and prostaglandins, which amplify and coordinate the
        inflammatory response.</li>
      <li><strong>Tissue repair:</strong> Inflammation triggers the activation of cells involved in tissue repair, such
        as fibroblasts, leading to the formation of new blood vessels and scar tissue.</li>
    </ul>
    <h2>Historical Highlights</h2>
    <p>Throughout history, scientists and physicians have made significant contributions to our understanding of
      inflammation. From the ancient Greeks to modern researchers, several key discoveries have shaped our knowledge of
      the inflammatory process.</p>
    <h2>Causes of Inflammation</h2>
    <p>Inflammation can be triggered by various factors, including:</p>
    <ul>
      <li><strong>Infections:</strong> Pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, can
        initiate an immune response and cause inflammation.</li>
      <li><strong>Tissue necrosis:</strong> Cell death due to injury, trauma, or ischemia can activate the inflammatory
        response.</li>
      <li><strong>Foreign bodies:</strong> Presence of non-living materials, such as splinters, implants, or
        environmental particles, can trigger inflammation.</li>
      <li><strong>Immune reactions:</strong> Inflammatory responses can be initiated by an abnormal immune response to
        self-antigens, leading to autoimmune disorders.</li>
    </ul>
    <h2>Recognition of Microbes and Damaged Cells</h2>
    <p>The recognition of microbes and damaged cells is crucial for initiating the inflammatory response. It involves
      various cellular receptors and sensors, including:</p>
    <ul>
      <li><strong>Cellular receptors for microbes:</strong> Pattern recognition receptors (PRRs), such as Toll-like
        receptors (TLRs), recognize specific molecular patterns associated with pathogens and trigger immune responses.
      </li>
      <li><strong>Sensors of cell damage:</strong> Certain molecules released from damaged cells, such as ATP and DNA,
        can be sensed by specific receptors, signaling the presence of tissue injury.</li>
      <li><strong>Other cellular receptors involved in inflammation:</strong> Besides PRRs and damage sensors, other
        receptors on immune cells, such as cytokine receptors and chemokine receptors, contribute to the regulation and
        amplification of the inflammatory response.</li>
    </ul>
    <h2>Circulating Proteins</h2>
    <p>Circulating proteins play essential roles in inflammation. Some examples include:</p>
    <ul>
      <li><strong>Complement system:</strong> Complement proteins can be activated and contribute to the inflammatory
        response by promoting chemotaxis, opsonization, and cell lysis.</li>
      <li><strong>Cytokines and chemokines:</strong> These small signaling molecules are secreted by immune cells and
        other cells to regulate inflammation, immune cell recruitment, and cell-to-cell communication.</li>
      <li><strong>Acute-phase proteins:</strong> During inflammation, the liver produces acute-phase proteins, such as
        C-reactive protein (CRP), which can serve as markers of inflammation and contribute to the immune response.</li>
    </ul>



















    <h1>Acute Inflammation</h1>
    <h2>Reactions of Blood Vessels in Acute Inflammation</h2>
    <h3>Changes in Vascular Flow and Caliber</h3>
    <p>In acute inflammation, the blood vessels undergo specific changes to facilitate the inflammatory response. These
      changes include:</p>
    <ul>
      <li><strong>Vasodilation:</strong> Blood vessels near the site of inflammation dilate, leading to increased blood
        flow. This increased blood flow causes redness and heat in the affected area.</li>
      <li><strong>Increased vascular permeability:</strong> The permeability of blood vessels is increased, allowing
        fluid, proteins, and immune cells to move from the bloodstream into the tissues. This vascular leakage leads to
        swelling.</li>
    </ul>
    <h3>Responses of Lymphatic Vessels and Lymph Nodes</h3>
    <p>Lymphatic vessels and lymph nodes play a crucial role in the inflammatory response. They help remove excess fluid
      and cellular debris from the inflamed tissues and facilitate the transportation of immune cells. Lymph nodes also
      serve as sites for immune cell activation and interaction.</p>
    <h2>Leukocyte Recruitment to Sites of Inflammation</h2>
    <p>Leukocytes, particularly neutrophils and monocytes, are key players in acute inflammation. They are recruited
      from the bloodstream to the site of inflammation in a multistep process, which includes:</p>
    <h3>Leukocyte Adhesion to Endothelium</h3>
    <p>Leukocytes adhere to the endothelial cells lining the blood vessels at the site of inflammation. This adhesion is
      mediated by interactions between adhesion molecules expressed on the leukocytes and endothelial cells. Selectins,
      integrins, and immunoglobulin superfamily molecules are involved in leukocyte-endothelial cell adhesion.</p>
    <h3>Leukocyte Migration Through Endothelium</h3>
    <p>After adhesion, leukocytes migrate through the endothelium and enter the inflamed tissues. They move between
      endothelial cells through a process called transmigration or diapedesis.</p>
    <h3>Chemotaxis of Leukocytes</h3>
    <p>Chemotaxis is the directed movement of leukocytes along a gradient of chemical signals. In response to
      inflammatory mediators, such as chemokines, leukocytes are guided to the site of inflammation.</p>
    <h2>Phagocytosis and Clearance of the Offending Agent</h2>
    <h3>Phagocytosis</h3>
    <p>Phagocytosis is the process by which cells, such as neutrophils and macrophages, engulf and internalize
      particles, including microbes and cellular debris. It involves several steps:</p>
    <h4>Phagocytic Receptors</h4>
    <p>Phagocytic receptors on the surface of phagocytes recognize and bind to specific molecules on the target
      particles. These receptors include pattern recognition receptors (PRRs) and opsonin receptors.</p>
    <h4>Engulfment</h4>
    <p>Once the target particle is bound to the phagocyte, the plasma membrane extends around it, forming a phagosome.
      The phagosome then fuses with lysosomes to form a phagolysosome, where the contents are degraded.</p>
    <h3>Intracellular Destruction of Microbes and Debris</h3>
    <p>Within the phagolysosome, the phagocyte employs various mechanisms to destroy the ingested microbes and cellular
      debris:</p>
    <h4>Reactive Oxygen Species</h4>
    <p>Phagocytes produce reactive oxygen species (ROS), such as superoxide anion, hydrogen peroxide, and hypochlorous
      acid, which have antimicrobial properties and aid in the destruction of engulfed particles.</p>
    <h4>Nitric Oxide</h4>
    <p>Macrophages produce nitric oxide (NO), which also has antimicrobial effects and contributes to the intracellular
      killing of microbes.</p>
    <h4>Lysosomal Enzymes and Other Lysosomal Proteins</h4>
    <p>Lysosomal enzymes, including proteases, nucleases, and lipases, are released into the phagolysosome, where they
      degrade the ingested material. Other lysosomal proteins, such as defensins and cathelicidins, also participate in
      microbial killing.</p>
    <h3>Neutrophil Extracellular Traps</h3>
    <p>Neutrophils can release extracellular traps called neutrophil extracellular traps (NETs) to capture and kill
      microbes. NETs are composed of DNA, histones, and antimicrobial proteins, forming a mesh-like structure that
      immobilizes the pathogens.</p>
    <h3>Leukocyte-Mediated Tissue Injury</h3>
    <p>In the process of combating infection and inflammation, activated leukocytes can inadvertently cause tissue
      damage. This can occur due to the release of toxic substances, such as proteases and reactive oxygen species, or
      by inducing an excessive immune response.</p>
    <h3>Other Functional Responses of Activated Leukocytes</h3>
    <p>Activated leukocytes also release various cytokines, chemokines, and lipid mediators that contribute to the
      inflammatory response, recruit additional immune cells, and promote tissue repair.</p>
    <h2>Termination of the Acute Inflammatory Response</h2>
    <p>The acute inflammatory response is self-limiting and eventually resolves. Several mechanisms contribute to the
      termination of inflammation, including the removal of inflammatory stimuli, resolution of tissue injury, and the
      action of anti-inflammatory molecules and regulatory cells.</p>












    <h2>Mediators of Inflammation</h2>
    <h3>Vasoactive Amines: Histamine and Serotonin</h3>
    <p>Vasoactive amines, such as histamine and serotonin, play a significant role in mediating the vascular changes
      associated with inflammation.</p>
    <p><b>Histamine:</b> Histamine is released mainly from mast cells and basophils in response to various stimuli, such
      as tissue injury, immune reactions, or allergic responses. It acts on histamine receptors located on endothelial
      cells, causing vasodilation and increased vascular permeability. Vasodilation leads to the widening of blood
      vessels, allowing increased blood flow to the site of inflammation. Increased vascular permeability allows plasma
      proteins, immune cells, and other inflammatory mediators to extravasate into the affected tissues, contributing to
      the inflammatory response.</p>
    <p><b>Serotonin:</b> Serotonin, also known as 5-hydroxytryptamine (5-HT), is released from platelets during platelet
      aggregation and activation. Similar to histamine, serotonin promotes vasodilation and enhances the effects of
      other mediators, contributing to increased vascular permeability. Serotonin also acts as a chemotactic agent,
      attracting leukocytes to the site of inflammation.</p>
    <h3>Arachidonic Acid Metabolites</h3>
    <p>Arachidonic acid, derived from cell membrane phospholipids, is metabolized by two major pathways: the
      cyclooxygenase (COX) pathway and the lipoxygenase (LOX) pathway. These pathways give rise to various eicosanoids,
      which are important mediators of inflammation.</p>
    <h4>Prostaglandins:</h4>
    <p>Prostaglandins are synthesized by the action of cyclooxygenase enzymes, particularly COX-1 and COX-2.
      Prostaglandins have diverse effects in inflammation. They induce vasodilation, increase vascular permeability, and
      promote chemotaxis of immune cells to the site of inflammation. Prostaglandins also modulate immune cell
      functions, such as promoting the activation of neutrophils and monocytes.</p>
    <p>Examples of prostaglandins involved in inflammation include prostaglandin E2 (PGE2) and prostacyclin (PGI2). PGE2
      enhances vasodilation and vascular permeability, while PGI2 has potent vasodilatory effects and inhibits platelet
      aggregation.</p>
    <h4>Leukotrienes:</h4>
    <p>Leukotrienes are produced by the action of 5-lipoxygenase (5-LO) on arachidonic acid. They are potent mediators
      of inflammation, particularly in allergic and asthmatic reactions. Leukotrienes, such as leukotriene B4 (LTB4) and
      the cysteinyl leukotrienes (LTC4, LTD4, LTE4), promote chemotaxis and activation of leukocytes, leading to
      increased vascular permeability, smooth muscle contraction, and mucus secretion.</p>
    <h4>Lipoxins:</h4>
    <p>Lipoxins are specialized pro-resolving mediators formed during the resolution phase of inflammation. They are
      derived from arachidonic acid through interactions between lipoxygenases and aspirin-acetylated COX-2. Lipoxins
      have anti-inflammatory actions and actively promote the resolution of inflammation by inhibiting neutrophil
      recruitment, enhancing phagocytosis of apoptotic cells, and stimulating the production of anti-inflammatory
      cytokines.</p>
    <h4>Pharmacologic Inhibitors of Prostaglandins and Leukotrienes:</h4>
    <p>Nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, inhibit the activity of COX
      enzymes, thereby reducing the synthesis of prostaglandins. Similarly, drugs called leukotriene inhibitors, such as
      montelukast and zafirlukast, block the action of leukotrienes by targeting their receptors or inhibiting their
      synthesis, providing relief in conditions such as asthma and allergic reactions.</p>
    <h3>Cytokines and Chemokines</h3>
    <p>Cytokines and chemokines are small signaling proteins that play crucial roles in inflammation by regulating
      immune cell recruitment, activation, and communication.</p>
    <h4>Tumor Necrosis Factor (TNF) and Interleukin-1 (IL-1):</h4>
    <p>TNF and IL-1 are key pro-inflammatory cytokines produced mainly by macrophages and other immune cells. They are
      involved in the early stages of inflammation and have broad effects on multiple cell types.</p>
    <p><b>Endothelial activation:</b> TNF and IL-1 induce the activation of endothelial cells, leading to increased
      expression of adhesion molecules on the endothelial surface. This promotes leukocyte adhesion to endothelial cells
      and subsequent transmigration into the inflamed tissue.</p>
    <p><b>Activation of leukocytes and other cells:</b> TNF and IL-1 enhance the activation and functions of immune
      cells, such as neutrophils and macrophages. They promote the release of other inflammatory mediators, such as
      cytokines, chemokines, and enzymes, amplifying the inflammatory response.</p>
    <p><b>Systemic acute-phase response:</b> TNF and IL-1 contribute to the systemic acute-phase response, which
      includes fever, increased production of acute-phase proteins in the liver, and mobilization of energy stores.</p>
    <h4>Chemokines:</h4>
    <p>Chemokines are a family of small proteins that guide leukocyte migration during inflammation and immune
      responses. They are classified into four major subfamilies based on the arrangement of conserved cysteine
      residues: C-X-C chemokines, C-C chemokines, C chemokines, and CX3C chemokines.</p>
    <p><b>Types of Chemokines:</b> Chemokines have diverse functions and are expressed in a context-specific manner.
      They attract specific subsets of leukocytes to the site of inflammation, promote their adhesion and migration, and
      modulate their activation and effector functions.</p>
    <p><b>In acute inflammation:</b> Chemokines play a crucial role in recruiting neutrophils, the first responders to
      the site of injury or infection. Examples of chemokines involved in acute inflammation include IL-8 (CXCL8), which
      attracts neutrophils, and CCL2, which recruits monocytes.</p>
    <p><b>Maintenance of tissue architecture:</b> Chemokines are also involved in maintaining tissue architecture and
      homeostasis by guiding the migration of immune cells during normal physiological processes, such as immune
      surveillance and tissue repair.</p>
    <h4>Other Cytokines in Acute Inflammation:</h4>
    <p>Besides TNF and IL-1, other cytokines, such as IL-6, IL-17, and interferons, play important roles in regulating
      the inflammatory response. IL-6 is involved in the systemic acute-phase response and the activation of
      lymphocytes. IL-17 promotes the recruitment and activation of neutrophils. Interferons have antiviral and
      immunomodulatory effects.</p>
    <h3>Complement System</h3>
    <p>The complement system consists of a group of proteins that play a crucial role in inflammation and host defense
      against pathogens.</p>
    <p><b>Classical pathway:</b> The classical pathway is activated by immune complexes formed by antibodies bound to
      antigens. Activation of the classical pathway leads to the production of anaphylatoxins (C3a and C5a) and the
      formation of the membrane attack complex, resulting in cell lysis.</p>
    <p><b>Alternative pathway:</b> The alternative pathway can be activated by microbial surfaces and certain
      inflammatory mediators. It leads to the production of anaphylatoxins and the formation of the membrane attack
      complex.</p>
    <p><b>Lectin pathway:</b> The lectin pathway is activated by pattern recognition molecules called mannose-binding
      lectins (MBL) that bind to microbial carbohydrates. Activation of the lectin pathway triggers similar downstream
      events as the classical and alternative pathways.</p>
    <h3>Other Mediators of Inflammation</h3>
    <p><b>Platelet-Activating Factor (PAF):</b> PAF is a phospholipid mediator involved in various inflammatory
      processes. It is produced by several cell types, including leukocytes, platelets, and endothelial cells. PAF
      induces platelet aggregation, vasodilation, increased vascular permeability, leukocyte activation, and chemotaxis.
    </p>
    <p><b>Products of Coagulation:</b> Components of the coagulation system, such as fibrinopeptides and thrombin, can
      activate and amplify the inflammatory response. They contribute to the recruitment and activation of leukocytes,
      modulate vascular permeability, and stimulate the production of cytokines and chemokines.</p>
    <p><b>Kinins:</b> Kinins, such as bradykinin, are vasoactive peptides generated from precursor molecules during the
      activation of the coagulation and complement systems. They induce vasodilation, increased vascular permeability,
      and the activation of nociceptors, leading to pain sensation.</p>
    <p><b>Neuropeptides:</b> Neuropeptides, such as substance P and calcitonin gene-related peptide (CGRP), are released
      from sensory nerve endings during inflammation. They contribute to vasodilation, increased vascular permeability,
      and the activation of immune cells and mast cells.</p>











    <h2>Morphologic Patterns of Acute Inflammation</h2>
    <h3>Serous Inflammation</h3>
    <p>Serous inflammation is characterized by the exudation of a watery, protein-rich fluid called serous fluid. It
      typically occurs in tissues with a thin lining, such as the skin or serous cavities. Serous inflammation is often
      seen in mild injuries or early stages of inflammation.</p>
    <h3>Fibrinous Inflammation</h3>
    <p>Fibrinous inflammation is characterized by the deposition of fibrin, a fibrous protein, within the inflamed
      tissue. Fibrin forms a mesh-like network that can be seen macroscopically. Fibrinous inflammation occurs in more
      severe or prolonged inflammatory responses and is commonly seen in infections, such as pneumonia or pericarditis.
    </p>
    <h3>Purulent (Suppurative) Inflammation, Abscess</h3>
    <p>Purulent inflammation, also known as suppurative inflammation, is characterized by the presence of pus. Pus is a
      creamy, yellowish fluid composed of dead cells, debris, and fluid. It is often associated with bacterial
      infections and can lead to the formation of an abscess, which is a localized collection of pus within a tissue or
      organ.</p>
    <h3>Ulcers</h3>
    <p>Ulcers are defects or erosions in the surface of tissues, often resulting from necrosis (cell death) and
      inflammation. They can occur in various organs, such as the gastrointestinal tract or skin, and are characterized
      by the loss of tissue layers.</p>
    <h2>Outcomes of Acute Inflammation</h2>
    <p>The outcomes of acute inflammation depend on the severity, duration, and effectiveness of the inflammatory
      response, as well as the specific tissue or organ involved. The possible outcomes include:</p>
    <ul>
      <li><strong>Resolution:</strong> The inflammatory response successfully eliminates the injurious stimulus, and the
        tissue returns to its normal structure and function.</li>
      <li><strong>Healing by connective tissue replacement:</strong> If the tissue damage is extensive or if the tissue
        has limited regenerative capacity, connective tissue components, such as collagen, may replace the damaged
        tissue, leading to scar formation.</li>
      <li><strong>Chronic inflammation:</strong> In some cases, the inflammatory response persists or recurs, leading to
        chronic inflammation. Chronic inflammation can cause progressive tissue damage and may be associated with
        underlying diseases, such as autoimmune disorders or persistent infections.</li>
    </ul>
    <h2>Summary of Acute Inflammation</h2>
    <p>Acute inflammation is a complex and dynamic process involving the coordinated response of various cells and
      molecules. It is characterized by changes in blood vessels, recruitment of leukocytes, phagocytosis, and tissue
      repair. The morphologic patterns of acute inflammation can vary, ranging from serous inflammation to fibrinous
      inflammation, purulent inflammation (suppuration), and the formation of ulcers. The outcome of acute inflammation
      can include resolution, healing by connective tissue replacement, or progression to chronic inflammation.</p>











    <h1>Chronic Inflammation</h1>
    <h2>Causes of Chronic Inflammation</h2>
    <p>Chronic inflammation can arise from persistent or recurrent exposure to injurious stimuli, including:</p>
    <ul>
      <li><strong>Infections:</strong> Certain infections, such as tuberculosis, fungal infections, and chronic viral
        infections, can trigger chronic inflammation.</li>
      <li><strong>Tissue injury and necrosis:</strong> Prolonged tissue damage and necrosis, often caused by persistent
        irritants, can lead to chronic inflammation.</li>
      <li><strong>Foreign bodies:</strong> Presence of non-degradable foreign bodies, such as sutures, implants, or
        splinters, can elicit chronic inflammation.</li>
      <li><strong>Autoimmune diseases:</strong> Autoimmune disorders, such as rheumatoid arthritis and systemic lupus
        erythematosus, can result in chronic inflammation due to the immune system mistakenly attacking healthy tissues.
      </li>
      <li><strong>Persistent immune reactions:</strong> Chronic inflammation can occur when the immune system responds
        continuously to persistent antigens, leading to sustained activation of immune cells.</li>
    </ul>
    <h2>Morphologic Features</h2>
    <p>Chronic inflammation is characterized by distinct morphologic features that distinguish it from acute
      inflammation:</p>
    <ul>
      <li><strong>Infiltration of immune cells:</strong> The affected tissue exhibits infiltration of lymphocytes,
        plasma cells, macrophages, and occasionally, granulocytes.</li>
      <li><strong>Tissue destruction and fibrosis:</strong> Chronic inflammation can lead to tissue destruction and the
        deposition of fibrous connective tissue, resulting in scarring and impaired organ function.</li>
      <li><strong>Angiogenesis:</strong> Formation of new blood vessels, known as angiogenesis, can occur in chronically
        inflamed tissues as a response to ongoing inflammation.</li>
      <li><strong>Presence of granulomas:</strong> In some cases, chronic inflammation is associated with the formation
        of granulomas, which are aggregates of immune cells, primarily macrophages, surrounded by a rim of lymphocytes.
      </li>
    </ul>
    <h2>Cells and Mediators of Chronic Inflammation</h2>
    <h3>Role of Macrophages</h3>
    <p>Macrophages play a central role in chronic inflammation. They not only engulf and degrade pathogens but also
      release various mediators, including cytokines, chemokines, growth factors, and enzymes. Macrophages can persist
      at the site of inflammation and contribute to tissue damage and remodeling.</p>
    <h3>Role of Lymphocytes</h3>
    <p>Lymphocytes, particularly T lymphocytes and B lymphocytes, are involved in chronic inflammation. T lymphocytes
      secrete cytokines that recruit and activate other immune cells, whereas B lymphocytes produce antibodies that
      target specific antigens. Both T and B lymphocytes contribute to the perpetuation of chronic inflammation and
      tissue damage.</p>
    <h3>Other Cells in Chronic Inflammation</h3>
    <p>Other cells, such as neutrophils, eosinophils, mast cells, and fibroblasts, can also be present in chronic
      inflammatory lesions. Neutrophils are typically less prominent in chronic inflammation compared to acute
      inflammation. Eosinophils are associated with allergic and parasitic reactions. Mast cells release inflammatory
      mediators, and fibroblasts contribute to tissue repair and scarring.</p>
    <h2>Granulomatous Inflammation</h2>
    <p>Granulomatous inflammation is a specific form of chronic inflammation characterized by the formation of
      granulomas. Granulomas are aggregates of macrophages, often surrounded by a rim of lymphocytes, and can be seen in
      various infectious and non-infectious conditions, such as tuberculosis, sarcoidosis, and foreign body reactions.
      Granulomatous inflammation represents an attempt by the immune system to contain persistent or indigestible
      stimuli.</p>















    <h1>Systemic Effects of Inflammation</h1>
    <p>Inflammation is not limited to the site of injury or infection but can also exert systemic effects throughout the
      body. These systemic effects are mediated by circulating inflammatory mediators and immune cells. Some of the key
      systemic effects of inflammation include:</p>
    <ul>
      <li><strong>Fever:</strong> Inflammatory mediators, particularly cytokines like interleukin-1 (IL-1) and tumor
        necrosis factor-alpha (TNF-alpha), can act on the hypothalamus, leading to an elevation in body temperature and
        fever.</li>
      <li><strong>Acute-phase response:</strong> In response to inflammation, the liver produces acute-phase proteins,
        such as C-reactive protein (CRP) and fibrinogen, which contribute to the immune response, tissue repair, and
        modulating systemic inflammation.</li>
      <li><strong>Leukocytosis:</strong> Inflammatory mediators stimulate the release of white blood cells, particularly
        neutrophils, from the bone marrow, resulting in an increased number of circulating leukocytes.</li>
      <li><strong>Increased vascular permeability:</strong> Systemic inflammation can lead to generalized increase in
        vascular permeability, resulting in edema formation and fluid shifts.</li>
      <li><strong>Altered cardiovascular function:</strong> Inflammatory mediators can affect cardiovascular function by
        inducing vasodilation, altering vascular tone, and promoting the adhesion of leukocytes to the endothelium.</li>
      <li><strong>Metabolic changes:</strong> Inflammation can lead to alterations in metabolism, including changes in
        glucose metabolism, lipid metabolism, and protein metabolism.</li>
      <li><strong>Malaise and fatigue:</strong> Systemic inflammation often causes symptoms of malaise, fatigue, and
        generalized discomfort.</li>
    </ul>
    <h1>Tissue Repair</h1>
    <h2>Overview of Tissue Repair</h2>
    <p>Tissue repair is the process by which injured or damaged tissues are replaced by newly formed functional tissue.
      It involves a complex series of events that aim to restore tissue integrity and function. The process of tissue
      repair typically consists of three overlapping phases:</p>
    <ol>
      <li><strong>Inflammation:</strong> Inflammation initiates the tissue repair process by clearing debris,
        eliminating pathogens, and releasing various growth factors and cytokines that promote subsequent repair
        processes.</li>
      <li><strong>Proliferation:</strong> During this phase, new cells are generated to replace the damaged or lost
        tissue. Angiogenesis, the formation of new blood vessels, also occurs to provide oxygen and nutrients to the
        healing tissue.</li>
      <li><strong>Remodeling:</strong> In this final phase, the newly formed tissue undergoes remodeling and maturation,
        involving the reorganization of extracellular matrix components and the strengthening of the tissue.</li>
    </ol>
    <h1>Cell and Tissue Regeneration</h1>
    <h2>Cell Proliferation: Signals and Control Mechanisms</h2>
    <p>Cell proliferation plays a crucial role in tissue regeneration. It is controlled by a complex interplay of
      signals and regulatory mechanisms. Various growth factors, such as epidermal growth factor (EGF), platelet-derived
      growth factor (PDGF), and fibroblast growth factor (FGF), stimulate cell proliferation by binding to specific cell
      surface receptors and activating intracellular signaling pathways.</p>
    <h2>Mechanisms of Tissue Regeneration</h2>
    <h3>Liver Regeneration</h3>
    <p>The liver is a remarkable organ with a high regenerative capacity. In response to injury or surgical resection,
      the remaining hepatocytes undergo a process called compensatory hyperplasia, leading to the restoration of liver
      mass and function. The key steps involved in liver regeneration include:</p>
    <ol>
      <li><strong>Primed hepatocytes:</strong> Quiescent hepatocytes near the injured area are primed to enter the cell
        cycle and undergo proliferation.</li>
      <li><strong>Initiation of regeneration:</strong> Inflammatory cytokines and growth factors, such as IL-6 and
        hepatocyte growth factor (HGF), stimulate the primed hepatocytes to enter the cell cycle.</li>
      <li><strong>Cell proliferation:</strong> The primed hepatocytes undergo multiple rounds of cell division,
        resulting in the expansion of the hepatocyte population.</li>
      <li><strong>Restoration of liver structure and function:</strong> As the hepatocytes proliferate, they
        re-establish the liver's architecture and metabolic functions, leading to the restoration of liver mass and
        function.</li>
    </ol>












    <h1>Repair by Connective Tissue Deposition</h1>
    <h2>Steps in Scar Formation</h2>
    <p>Scar formation is a crucial step in the repair process following tissue injury. The process involves several
      distinct steps:</p>
    <ul>
      <li><strong>Inflammation:</strong> Inflammation is the initial response to tissue injury and provides the
        necessary signals to initiate the repair process. It involves the recruitment of immune cells, release of
        inflammatory mediators, and clearance of debris.</li>
      <li><strong>Angiogenesis:</strong> Angiogenesis, the formation of new blood vessels, is crucial for delivering
        oxygen, nutrients, and immune cells to the injured area. Endothelial cells sprout and proliferate, forming new
        capillaries that support the repair process.</li>
      <li><strong>Deposition of Connective Tissue:</strong> Fibroblasts, activated by growth factors and cytokines,
        migrate to the injury site and synthesize collagen and other extracellular matrix components. This leads to the
        formation of a provisional matrix that provides structural support to the healing tissue.</li>
      <li><strong>Remodeling of Connective Tissue:</strong> Over time, the initial provisional matrix is remodeled by
        the action of matrix metalloproteinases (MMPs) and other enzymes. This remodeling process helps to refine the
        tissue structure and restore its strength and function.</li>
    </ul>
    <h2>Angiogenesis</h2>
    <p>Angiogenesis, the formation of new blood vessels, is a critical component of tissue repair. It ensures an
      adequate blood supply to the healing tissue, delivering oxygen, nutrients, and immune cells. The process of
      angiogenesis involves the following steps:</p>
    <ul>
      <li><strong>Vasodilation:</strong> Blood vessels near the injury site dilate, increasing blood flow to the area.
      </li>
      <li><strong>Endothelial cell activation:</strong> Endothelial cells lining existing blood vessels become activated
        and migrate towards the injury site.</li>
      <li><strong>Endothelial cell proliferation and sprouting:</strong> Activated endothelial cells proliferate and
        form sprouts that extend into the surrounding tissue.</li>
      <li><strong>Tube formation and maturation:</strong> Endothelial sprouts fuse to form tube-like structures, which
        then mature into functional blood vessels.</li>
      <li><strong>Stabilization and recruitment of pericytes:</strong> Pericytes, specialized cells, associate with the
        newly formed blood vessels, providing structural support and promoting vessel stability.</li>
    </ul>
    <h2>Deposition of Connective Tissue</h2>
    <p>Deposition of connective tissue is a crucial step in tissue repair, especially in cases where the injury involves
      extensive damage or loss of tissue. Fibroblasts play a key role in this process by synthesizing and depositing
      extracellular matrix components, particularly collagen. The deposition of connective tissue provides a scaffold
      for cell migration, supports tissue structure, and helps restore tissue integrity.</p>
    <h2>Remodeling of Connective Tissue</h2>
    <p>Remodeling of connective tissue is an essential phase of tissue repair, ensuring the proper organization and
      function of the healed tissue. During remodeling, the provisional matrix undergoes structural modifications and
      realignment of collagen fibers. This process is regulated by the coordinated action of various enzymes, including
      matrix metalloproteinases (MMPs), which degrade and modify the extracellular matrix components. The remodeling
      phase can extend over a prolonged period, often lasting several months or even years, and results in the
      maturation of the scar tissue.</p>
    <h1>Factors That Influence Tissue Repair</h1>
    <p>Tissue repair is a complex process influenced by various factors. Several intrinsic and extrinsic factors can
      impact the efficiency and outcome of the repair process. Some key factors that influence tissue repair include:
    </p>
    <ul>
      <li><strong>Age:</strong> Advanced age can affect the regenerative capacity of tissues, leading to delayed or
        impaired healing.</li>
      <li><strong>Nutrition:</strong> Adequate nutrition, including a balanced intake of macronutrients and
        micronutrients, is crucial for supporting cell proliferation, collagen synthesis, and overall tissue repair.
      </li>
      <li><strong>Systemic factors:</strong> Certain systemic conditions, such as diabetes, immune disorders, and
        cardiovascular diseases, can interfere with the normal healing process.</li>
      <li><strong>Infection:</strong> Infections can delay or disrupt the repair process, leading to chronic
        inflammation and impaired healing.</li>
      <li><strong>Mechanical factors:</strong> Mechanical factors, such as tension or compression on the healing tissue,
        can influence the quality and strength of the repaired tissue.</li>
    </ul>
    <h1>Selected Clinical Examples of Tissue Repair and Fibrosis</h1>
    <h2>Healing of Skin Wounds</h2>
    <p>Wound healing in the skin can occur through two primary mechanisms: healing by first intention (primary
      intention) and healing by second intention (secondary intention).</p>
    <h3>Healing by First Intention</h3>
    <p>Healing by first intention occurs in clean, well-approximated surgical incisions or small wounds with minimal
      tissue loss. The process involves the following steps:</p>
    <ol>
      <li><strong>Initial inflammation:</strong> Inflammatory cells migrate to the wound site, removing debris and
        preparing the area for healing.</li>
      <li><strong>Epithelialization:</strong> Epithelial cells at the wound edges proliferate and migrate to cover the
        wound surface, forming a thin layer of new epithelium.</li>
      <li><strong>Granulation tissue formation:</strong> Fibroblasts synthesize collagen and other extracellular matrix
        components, creating granulation tissue that fills the wound space.</li>
      <li><strong>Remodeling:</strong> The granulation tissue undergoes remodeling, with collagen fibers reorganizing
        and gaining strength.</li>
      <li><strong>Scar formation:</strong> The healed wound forms a scar, which gradually matures and becomes less
        visible over time.</li>
    </ol>
    <h3>Healing by Second Intention</h3>
    <p>Healing by second intention occurs in larger wounds with tissue loss or when wound edges cannot be directly
      approximated. The process involves:</p>
    <ol>
      <li><strong>Inflammatory response:</strong> The initial inflammatory response is similar to healing by first
        intention.</li>
      <li><strong>Wound contraction:</strong> Myofibroblasts, specialized cells with contractile properties, help reduce
        the wound size by contracting the edges towards the center.</li>
      <li><strong>Granulation tissue formation:</strong> Granulation tissue fills the wound space, as in healing by
        first intention.</li>
      <li><strong>Remodeling and scar formation:</strong> The granulation tissue is remodeled over time, leading to scar
        formation.</li>
    </ol>
    <h3>Wound Strength</h3>
    <p>The strength of a healed wound gradually increases over time as collagen synthesis and remodeling occur. However,
      the final strength of the scar tissue is generally lower than the original uninjured tissue.</p>
    <h2>Fibrosis in Parenchymal Organs</h2>
    <p>Fibrosis refers to the excessive deposition of collagen and other extracellular matrix components in parenchymal
      organs, leading to tissue scarring and loss of function. Fibrosis can occur in various organs, such as the liver,
      lungs, and kidneys, and is often a result of chronic inflammation, persistent injury, or repeated tissue damage.
      The excessive collagen deposition disrupts the normal tissue architecture and impairs organ function.</p>
    <h1>Abnormalities in Tissue Repair</h1>
    <p>Despite the body's intricate repair mechanisms, tissue repair can sometimes be imperfect or incomplete, leading
      to abnormalities. Some examples of abnormalities in tissue repair include:</p>
    <ul>
      <li><strong>Delayed healing:</strong> Healing process taking longer than expected or getting stuck in a particular
        phase, often due to factors such as poor circulation, infection, or underlying health conditions.</li>
      <li><strong>Hypertrophic scars and keloids:</strong> Excessive collagen deposition during wound healing can result
        in raised, thickened scars known as hypertrophic scars. Keloids are a type of hypertrophic scars that extend
        beyond the boundaries of the original wound.</li>
      <li><strong>Chronic non-healing wounds:</strong> Certain conditions, such as diabetic ulcers or venous ulcers, can
        result in chronic wounds that fail to progress through the normal stages of healing.</li>
      <li><strong>Adhesions:</strong> Abnormal connections between tissues or organs can form during the healing
        process, leading to adhesions that may cause pain, restricted movement, or organ dysfunction.</li>
    </ul>










  </div>

  <div id="questions-container" class="container" style="display:none">

  </div>

  <div id="videos-container" class="container" style="display:none">

  </div>

  <div id="remnant-container" class="container" style="display:none">

  </div>

</main>


  <footer>
    <p>&copy; 2023 GameChanger</p>
  </footer>
  <script>

    var contentPageLocation = "../contentRobbins.html";

  </script>
  <script src="/script/bookscript.js"></script>

</body>

</html>



